NCT04107610 is a NA clinical trial of I-PAS in Healthy, sponsored by Neurolign.

Who is sponsoring NCT04107610?

NCT04107610 is sponsored by Neurolign.

What drugs are being tested in NCT04107610?

Interventions in NCT04107610: I-PAS.

Is NCT04107610 still recruiting?

NCT04107610 is currently status unknown. Last updated 3 March 2021.

Last reviewed 2021-03-03 · How we verify

NCT04107610

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Normative Oculomotor and Vestibular Data in Pediatric Population

Status unknown NA Last updated 3 March 2021

What this trial tests

NA trial testing I-PAS in Healthy in 600 participants. Status unknown.

Timeline

1 April 2021

Primary endpoint
31 January 2022

31 August 2022

Quick facts

Lead sponsor	Neurolign
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	600
Start date	1 April 2021
Primary completion	31 January 2022
Estimated completion	31 August 2022
Sites	2 locations across United States

Drugs / interventions tested

I-PAS

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Neurolign

Who can join

Adults 6 to 18, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to use a device called I-Portal® Portable Assessment System (I-PAS) to record eye movements in response to a number of visual and auditory stimuli designed to evaluate neural brain pathways related to oculomotor, vestibular, reaction time and cognitive (OVRT-C) development. The goal of this research is to collect normative data for the OVRT-C tests from a healthy pediatric population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Neurolign trials

Trials by the same sponsor.

NCT04087044 — Computerized Rotational Head Impulse Test-Vertical (crHIT-vertical) · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04107610 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Neurolign
Last refreshed: 3 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04107610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing